MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Waters Corp

Closed

SectorHealthcare

287.21 -3.35

Overview

Share price change

24h

Current

Min

284.48

Max

297.07

Key metrics

By Trading Economics

Income

-110M

121M

Sales

-211M

662M

P/E

Sector Avg

27.628

39.857

EPS

2.25

Profit margin

18.344

Employees

7,600

EBITDA

-193M

152M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+33.71% upside

Dividends

By Dow Jones

Next Earnings

4 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-4.2B

18B

Previous open

290.56

Previous close

287.21

News Sentiment

By Acuity

65%

35%

325 / 376 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Waters Corp Chart

Past performance is not a reliable indicator of future results.

Related News

14 Jul 2025, 14:26 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 Jul 2025, 11:08 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 Jul 2025, 18:32 UTC

Acquisitions, Mergers, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 Jul 2025, 18:31 UTC

Acquisitions, Mergers, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 Jul 2025, 16:53 UTC

Hot Stocks

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 Jul 2025, 16:12 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 Jul 2025, 15:06 UTC

Acquisitions, Mergers, Takeovers

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 Jul 2025, 14:11 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 Jul 2025, 10:53 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 Jul 2025, 10:22 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 Jul 2025, 10:22 UTC

Acquisitions, Mergers, Takeovers

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 Jul 2025, 10:22 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 Jul 2025, 10:21 UTC

Acquisitions, Mergers, Takeovers

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 Jul 2025, 10:20 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 Jul 2025, 10:19 UTC

Acquisitions, Mergers, Takeovers

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 Jul 2025, 10:19 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 Jul 2025, 10:18 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 Jul 2025, 10:18 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 Jul 2025, 10:17 UTC

Acquisitions, Mergers, Takeovers

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 Jul 2025, 10:16 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 Jul 2025, 10:16 UTC

Acquisitions, Mergers, Takeovers

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 Jul 2025, 10:15 UTC

Acquisitions, Mergers, Takeovers

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 Jul 2025, 10:15 UTC

Acquisitions, Mergers, Takeovers

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Peer Comparison

Price change

Waters Corp Forecast

Price Target

By TipRanks

33.71% upside

12 Months Forecast

Average 397 USD  33.71%

High 500 USD

Low 330 USD

Based on 13 Wall Street analysts offering 12 month price targets forWaters Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

6

Buy

7

Hold

0

Sell

Technical Score

By Trading Central

345.22 / 351.01Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

325 / 376 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.